India Global News
Visit iGEN World(opens in a new tab)Explore iGEN Expo(opens in a new tab)
AI Plus
India Global News
Explore Upgrade Plan
Sign InRegister
Breaking
India signs $2B semiconductor deal with Netherlands — ASML to set up training center in BangaloreRBI holds rates steady at 6.5% — Export sector welcomes stability amid global uncertaintyIndia-UAE CEPA crosses $100B trade milestone — Services exports surge 40% YoYEuropean Central Bank signals digital euro interoperability with cross-border trade railsNASA commercial space expo unlocks $12B procurement pipeline for private aerospace corridorsIndia signs $2B semiconductor deal with Netherlands — ASML to set up training center in BangaloreRBI holds rates steady at 6.5% — Export sector welcomes stability amid global uncertaintyIndia-UAE CEPA crosses $100B trade milestone — Services exports surge 40% YoYEuropean Central Bank signals digital euro interoperability with cross-border trade railsNASA commercial space expo unlocks $12B procurement pipeline for private aerospace corridors
Back to News FeedHealth and Family WelfareUltratech Cement Posts 17.7% Revenue Growth as Health and Family Welfare Demand Offsets Margin Pressure
CompanyS33 · Health and Family WelfareFreeSummary

Ultratech Cement Posts 17.7% Revenue Growth as Health and Family Welfare Demand Offsets Margin Pressure

The company reported double-digit growth in its Health and Family Welfare business, and management says order visibility now extends well into next fiscal year.

RD
Rohan DeshpandeVERIFIED
Markets Editor, IGEN News
19 Oct 2026, 06:50 IST5 min read3.0K views

Updated 21 Oct 2026, 11:10 IST

Health and Family Welfare: illustrative image for "Ultratech Cement Posts 17.7% Revenue Growth as Health and Family Welfare Demand Offsets Margin Pressure"
Pharmaceuticals and healthcare: illustrative image for Health and Family Welfare coverage. Photo: Unsplash.
420
3
Sponsored

Trade finance for exporters: invoice discounting in 48 hours (partner content).

Ultratech Cement reported consolidated revenue growth of 17.7% for Q4 FY27, led by its Health and Family Welfare division, which contributed 28.9% of the total. Operating margin held at 7.7%, a few basis points below the previous quarter as higher logistics and wage costs offset operating leverage.

Environmental, social and governance targets also featured. The company reiterated its goal to reduce emissions intensity by a third by 2032, and disclosed that 28.9% of electricity at its main sites now comes from renewable sources under long-term contracts.

Key takeaways

  • Order book at $8.3 billion, roughly 14 months of revenue.
  • New facility near Chennai adds 1,887 tonnes of capacity and about 1,200 jobs.
  • Management flags input costs and clearance timing as key risks.
  • Revenue grew 17.7% in Q4 FY27; Health and Family Welfare contributed 28.9% of the total.
  • Capex guidance raised to $8.3 billion from $302 million.

The numbers

The company also announced a new facility near Chennai, designed to add about 1,887 tonnes of annual capacity and create roughly 1,200 jobs. Construction begins next quarter, and first production is targeted within 20 months. The plant will be built to meet European environmental standards.

Export performance was a bright spot. Shipments to Brazil rose 17.7%, helped by certification wins and shorter lead times from Chennai. Management said it would deepen its presence in the market by adding a local warehouse and a technical service team.

By the numbers

Revenue growth
+11.9%
YoY
consolidated revenue
Order book
$2.2B
14 months
order book
Operating margin
18.4%
-0.2 pts
operating margin
Net debt/EBITDA
1.1x
comfortable
net debt to EBITDA

Employees and communities are part of the plan: a skills academy near the new site will train 2,000 technicians over three years, funded jointly with the state government. Management said local hiring is a condition of the incentives it has received.

“Visibility is worth more than growth. We can plan investments when we can see 14 months ahead.”

Arvind Pillai, Chairman

Expansion and capital allocation

Capital expenditure guidance was raised to $8.3 billion for the fiscal year, from $302 million previously. Management said the increase reflects accelerated spending on automation and on debottlenecking existing lines, which it expects to deliver 7.7% more output without additional land.

Ultratech Cement quarterly revenue$ million
Ultratech Cement quarterly revenueUltratech Cement quarterly revenue: from 33.4 $ million in Q1 FY26 to 40.4 $ million in Q2 FY27; high 40.4 in Q2 FY27, low 33.4 in Q1 FY26.010.120.230.340.433.4Q1 FY2633.9Q2 FY2634.6Q3 FY2635.7Q4 FY2639.1Q1 FY2740.4Q2 FY27

Source: IGEN Intelligence analysis of igen intelligence database data. Illustrative mock data.

A new long-term agreement with Infosys anchors a portion of the expansion. The deal covers multi-year supply at index-linked pricing, with volume commitments that provide a floor, and includes a joint development programme for higher-specification products with better margins.

Segment performance for the quarter
SegmentRevenueYoYMargin
Health and Family Welfare (core)$121M+17.8%16.1%
Exports$50M+17.3%22.9%
Domestic retail$201M+9.1%24.1%
Services$262M-1.3%23.2%
Other$239M-0.8%17.9%
Source: Reserve Bank of India; IGEN estimates. Figures are illustrative mock data.

Customers, contracts and exports

On the post-results call, management said the order book now stands at $8.3 billion, equivalent to roughly 14 months of revenue, with about a third from export customers in Brazil and Germany. The chief financial officer described visibility as the best in five years.

Timeline of key events

  1. 17 Sep 2026
    Results announced

    Revenue up 17.7%; margin steady at 7.7%.

  2. 25 Sep 2026
    Capex raised

    Guidance moves to $8.3 billion to fund automation and debottlenecking.

  3. 3 Oct 2026
    Supply pact signed

    Multi-year agreement with Infosys at index-linked pricing.

  4. 11 Oct 2026
    Groundbreaking

    Construction at the new facility near Chennai begins.

  5. 19 Oct 2026
    First production

    Targeted within 20 months of groundbreaking.

Balance-sheet metrics remain comfortable. Net debt to earnings stood at 0.8 times, and the company retired $302 million of high-cost borrowings during the quarter. Credit analysts say the improvement leaves room to fund the expansion without equity dilution.

Expert commentary

“We are building where the customers are asking us to build. That is the simplest capital-allocation rule there is.”

TW
Dr. Tomas Weber
Senior Fellow, Berlin Institute for Trade

“Smaller firms are not at a disadvantage on quality; they are at a disadvantage on paperwork and finance.”

AP
Arvind Pillai
Chairman, Southern Ports Association

“What matters now is execution. The announcements are in place; the next two quarters will show who can deliver.”

VM
Vikram Malhotra
Industry Analyst, Manufacturing, IGEN Intelligence

Risks and analyst view

Analysts were broadly constructive. Of 18 brokerages covering the stock, 12 maintain buy ratings, with target prices implying about 28.9% upside. The more cautious voices pointed to a valuation premium and the execution risk inherent in a large expansion programme.

What it means for you

Investors

Order visibility and a manageable balance sheet support the story; track execution on the new plant and margin pass-through.

Suppliers

Expansion will lift procurement; engage early on qualification for the new lines.

Customers

Longer-term agreements offer price stability in exchange for volume commitments; compare index-linked terms carefully.

Job seekers

About 1,200 direct roles and a technician academy are planned near Chennai; applications open with the state skills portal.

Companies and leaders in this story

Ultratech Cement Mahindra Group Infosys Titan Company Nikhil Kamath Rakesh Bhargava

Frequently asked questions

Mainly volume in the Health and Family Welfare division and higher export realisations, partly offset by pricing pressure in domestic segments.

Sources

  1. IGEN Intelligence database: Proprietary tracker of announced projects
  2. Reserve Bank of India: Exchange-rate and trade-credit bulletins
  3. Central Board of Indirect Taxes & Customs: Port-level clearance and dwell data
  4. UN Comtrade: Bilateral trade flows by HS code

Mock content for demonstration. Names, figures and quotes are illustrative and not real reporting.

#HealthandFamilyWelfare#Company#Earnings#Expansion#Capex#Brazil
RD
Written by

Rohan Deshpande

Markets Editor, IGEN News

Tracks commodity benchmarks, currency moves and freight indices for importers and exporters.

Source & Editorial Attribution

Ministry of Health & Family Welfare · IGEN Trade Intelligence

This article is curated and summarized by the IGEN editorial desk. All text is verified from official filings and trade bulletins, rendered strictly in plain text for compliance and clarity. Full text and regulatory updates are archived in the national registry.

Daily briefing

Get stories like this in your inbox

One concise email each morning on trade, policy and markets across Health and Family Welfare and 49 other sectors.

Discussion (3)

Sort by: Most recent
Log in to comment
S
Smita Verma
38m ago

Useful numbers. Would love to see the same breakdown for smaller units, since they carry most of the compliance burden.

T
Tanvi Joshi
2h ago

Good to see concrete figures instead of generalities. The table on destination markets is especially helpful.

A
Ankit Sharma
5h ago

The point about documentation holds true on the ground. Our forwarder has already seen holds from template mismatches.

In this article
  1. 1. The numbers
  2. 2. Expansion and capital allocation
  3. 3. Customers, contracts and exports
  4. 4. Risks and analyst view
  5. 5. Discussion (3)

Trending now

  1. 01Compliance Window Opens for Chemicals Units as Ministry of Chemicals & Fertilizers Tightens Standards
  2. 02The Amit Chandra Interview: Why Banking Needs a Ten-Year View
  3. 03Inside India's Civil Aviation Build-Out: Capex, Bottlenecks and the 2029 Target
  4. 04Green Hydrogen to Grid Storage: Inside the Waste Management Transition Investments
  5. 05Compliance Window Opens for Logistics Units as Ministry of Commerce and Industry Tightens Standards
Topic
S33 · Health and Family Welfare

Ministry of Health & Family Welfare

BrazilGermany

More to read

All headlines →
Policy · Chemicals

Compliance Window Opens for Chemicals Units as Ministry of Chemicals & Fertilizers Tightens Standards

8 min read
Leader · Banking

The Amit Chandra Interview: Why Banking Needs a Ten-Year View

9 min read
Technology · Civil Aviation

Inside India's Civil Aviation Build-Out: Capex, Bottlenecks and the 2029 Target

10 min read
Sector · Waste Management

Green Hydrogen to Grid Storage: Inside the Waste Management Transition Investments

6 min read
Policy · Logistics

Compliance Window Opens for Logistics Units as Ministry of Commerce and Industry Tightens Standards

7 min read
Expert · Biotechnology

The Long Read: Biotechnology After the Tariff Reset

4 min read
India Global News

The premier institutional platform for global trade intelligence. Empowering 50,000+ professionals with real-time insights, bilateral trade corridors, and predictive analytics across 195 countries.

Stay Ahead of the Curve

Get daily trade intelligence briefings delivered to your inbox. Join 50k+ leaders. Delivered fresh before market opening.

Secure subscription. No spam. Strict data privacy.

Platform

  • Headlines
  • Trending
  • Company News
  • Leader News
  • Expert News
  • Sector News
  • Country News
  • Communities

Intelligence

  • Executive Decision Signals
  • Trade Policy Tracker
  • Bilateral Corridor Matrix
  • Live FDI & Capital Tracker
  • 60 Industrial Sectors
  • Predictive Signals

Events & Expo

  • Expert AMAs & Webinars
  • Executive Roundtables
  • Global Trade Summits
  • B2B Expo Network

Company

  • About iGEN
  • Membership Plans
  • Corporate Directory
  • CareersHiring
  • Contact
  • Advertise

Get In Touch

  • +91 11 4567 8900
  • contact@indiaglobalnews.org
  • New Delhi, India

© 2026 India Global News. All rights reserved.

iGEN is a registered trademark of Global Trade Intelligence Corp.

  • Privacy Policy
  • Terms of Service
  • Cookie Policy
  • Sitemap
System Operational
FeedCountryLeaderSearchProfile
📱Feed
🔥Headlines
📈Trending
🏢Company News
👑Leader News
🎓Expert News
🏭Sector News
🌐Country News
🤝Communities
👤My News
Back to News FeedHealth and Family WelfareUltratech Cement Posts 17.7% Revenue Growth as Health and Family Welfare Demand Offsets Margin Pressure
CompanyS33 · Health and Family WelfareFreeSummary

Ultratech Cement Posts 17.7% Revenue Growth as Health and Family Welfare Demand Offsets Margin Pressure

The company reported double-digit growth in its Health and Family Welfare business, and management says order visibility now extends well into next fiscal year.

RD
Rohan DeshpandeVERIFIED
Markets Editor, IGEN News
19 Oct 2026, 06:50 IST5 min read3.0K views

Updated 21 Oct 2026, 11:10 IST

Health and Family Welfare: illustrative image for "Ultratech Cement Posts 17.7% Revenue Growth as Health and Family Welfare Demand Offsets Margin Pressure"
Pharmaceuticals and healthcare: illustrative image for Health and Family Welfare coverage. Photo: Unsplash.
420
3
Sponsored

Trade finance for exporters: invoice discounting in 48 hours (partner content).

Ultratech Cement reported consolidated revenue growth of 17.7% for Q4 FY27, led by its Health and Family Welfare division, which contributed 28.9% of the total. Operating margin held at 7.7%, a few basis points below the previous quarter as higher logistics and wage costs offset operating leverage.

Environmental, social and governance targets also featured. The company reiterated its goal to reduce emissions intensity by a third by 2032, and disclosed that 28.9% of electricity at its main sites now comes from renewable sources under long-term contracts.

Key takeaways

  • Order book at $8.3 billion, roughly 14 months of revenue.
  • New facility near Chennai adds 1,887 tonnes of capacity and about 1,200 jobs.
  • Management flags input costs and clearance timing as key risks.
  • Revenue grew 17.7% in Q4 FY27; Health and Family Welfare contributed 28.9% of the total.
  • Capex guidance raised to $8.3 billion from $302 million.

The numbers

The company also announced a new facility near Chennai, designed to add about 1,887 tonnes of annual capacity and create roughly 1,200 jobs. Construction begins next quarter, and first production is targeted within 20 months. The plant will be built to meet European environmental standards.

Export performance was a bright spot. Shipments to Brazil rose 17.7%, helped by certification wins and shorter lead times from Chennai. Management said it would deepen its presence in the market by adding a local warehouse and a technical service team.

By the numbers

Revenue growth
+11.9%
YoY
consolidated revenue
Order book
$2.2B
14 months
order book
Operating margin
18.4%
-0.2 pts
operating margin
Net debt/EBITDA
1.1x
comfortable
net debt to EBITDA

Employees and communities are part of the plan: a skills academy near the new site will train 2,000 technicians over three years, funded jointly with the state government. Management said local hiring is a condition of the incentives it has received.

“Visibility is worth more than growth. We can plan investments when we can see 14 months ahead.”

Arvind Pillai, Chairman

Expansion and capital allocation

Capital expenditure guidance was raised to $8.3 billion for the fiscal year, from $302 million previously. Management said the increase reflects accelerated spending on automation and on debottlenecking existing lines, which it expects to deliver 7.7% more output without additional land.

Ultratech Cement quarterly revenue$ million
Ultratech Cement quarterly revenueUltratech Cement quarterly revenue: from 33.4 $ million in Q1 FY26 to 40.4 $ million in Q2 FY27; high 40.4 in Q2 FY27, low 33.4 in Q1 FY26.010.120.230.340.433.4Q1 FY2633.9Q2 FY2634.6Q3 FY2635.7Q4 FY2639.1Q1 FY2740.4Q2 FY27

Source: IGEN Intelligence analysis of igen intelligence database data. Illustrative mock data.

A new long-term agreement with Infosys anchors a portion of the expansion. The deal covers multi-year supply at index-linked pricing, with volume commitments that provide a floor, and includes a joint development programme for higher-specification products with better margins.

Segment performance for the quarter
SegmentRevenueYoYMargin
Health and Family Welfare (core)$121M+17.8%16.1%
Exports$50M+17.3%22.9%
Domestic retail$201M+9.1%24.1%
Services$262M-1.3%23.2%
Other$239M-0.8%17.9%
Source: Reserve Bank of India; IGEN estimates. Figures are illustrative mock data.

Customers, contracts and exports

On the post-results call, management said the order book now stands at $8.3 billion, equivalent to roughly 14 months of revenue, with about a third from export customers in Brazil and Germany. The chief financial officer described visibility as the best in five years.

Timeline of key events

  1. 17 Sep 2026
    Results announced

    Revenue up 17.7%; margin steady at 7.7%.

  2. 25 Sep 2026
    Capex raised

    Guidance moves to $8.3 billion to fund automation and debottlenecking.

  3. 3 Oct 2026
    Supply pact signed

    Multi-year agreement with Infosys at index-linked pricing.

  4. 11 Oct 2026
    Groundbreaking

    Construction at the new facility near Chennai begins.

  5. 19 Oct 2026
    First production

    Targeted within 20 months of groundbreaking.

Balance-sheet metrics remain comfortable. Net debt to earnings stood at 0.8 times, and the company retired $302 million of high-cost borrowings during the quarter. Credit analysts say the improvement leaves room to fund the expansion without equity dilution.

Expert commentary

“We are building where the customers are asking us to build. That is the simplest capital-allocation rule there is.”

TW
Dr. Tomas Weber
Senior Fellow, Berlin Institute for Trade

“Smaller firms are not at a disadvantage on quality; they are at a disadvantage on paperwork and finance.”

AP
Arvind Pillai
Chairman, Southern Ports Association

“What matters now is execution. The announcements are in place; the next two quarters will show who can deliver.”

VM
Vikram Malhotra
Industry Analyst, Manufacturing, IGEN Intelligence

Risks and analyst view

Analysts were broadly constructive. Of 18 brokerages covering the stock, 12 maintain buy ratings, with target prices implying about 28.9% upside. The more cautious voices pointed to a valuation premium and the execution risk inherent in a large expansion programme.

What it means for you

Investors

Order visibility and a manageable balance sheet support the story; track execution on the new plant and margin pass-through.

Suppliers

Expansion will lift procurement; engage early on qualification for the new lines.

Customers

Longer-term agreements offer price stability in exchange for volume commitments; compare index-linked terms carefully.

Job seekers

About 1,200 direct roles and a technician academy are planned near Chennai; applications open with the state skills portal.

Companies and leaders in this story

Ultratech Cement Mahindra Group Infosys Titan Company Nikhil Kamath Rakesh Bhargava

Frequently asked questions

Mainly volume in the Health and Family Welfare division and higher export realisations, partly offset by pricing pressure in domestic segments.

Sources

  1. IGEN Intelligence database: Proprietary tracker of announced projects
  2. Reserve Bank of India: Exchange-rate and trade-credit bulletins
  3. Central Board of Indirect Taxes & Customs: Port-level clearance and dwell data
  4. UN Comtrade: Bilateral trade flows by HS code

Mock content for demonstration. Names, figures and quotes are illustrative and not real reporting.

#HealthandFamilyWelfare#Company#Earnings#Expansion#Capex#Brazil
RD
Written by

Rohan Deshpande

Markets Editor, IGEN News

Tracks commodity benchmarks, currency moves and freight indices for importers and exporters.

Source & Editorial Attribution

Ministry of Health & Family Welfare · IGEN Trade Intelligence

This article is curated and summarized by the IGEN editorial desk. All text is verified from official filings and trade bulletins, rendered strictly in plain text for compliance and clarity. Full text and regulatory updates are archived in the national registry.

Daily briefing

Get stories like this in your inbox

One concise email each morning on trade, policy and markets across Health and Family Welfare and 49 other sectors.

Discussion (3)

Sort by: Most recent
Log in to comment
S
Smita Verma
38m ago

Useful numbers. Would love to see the same breakdown for smaller units, since they carry most of the compliance burden.

T
Tanvi Joshi
2h ago

Good to see concrete figures instead of generalities. The table on destination markets is especially helpful.

A
Ankit Sharma
5h ago

The point about documentation holds true on the ground. Our forwarder has already seen holds from template mismatches.

In this article
  1. 1. The numbers
  2. 2. Expansion and capital allocation
  3. 3. Customers, contracts and exports
  4. 4. Risks and analyst view
  5. 5. Discussion (3)

Trending now

  1. 01Compliance Window Opens for Chemicals Units as Ministry of Chemicals & Fertilizers Tightens Standards
  2. 02The Amit Chandra Interview: Why Banking Needs a Ten-Year View
  3. 03Inside India's Civil Aviation Build-Out: Capex, Bottlenecks and the 2029 Target
  4. 04Green Hydrogen to Grid Storage: Inside the Waste Management Transition Investments
  5. 05Compliance Window Opens for Logistics Units as Ministry of Commerce and Industry Tightens Standards
Topic
S33 · Health and Family Welfare

Ministry of Health & Family Welfare

BrazilGermany

More to read

All headlines →
Policy · Chemicals

Compliance Window Opens for Chemicals Units as Ministry of Chemicals & Fertilizers Tightens Standards

8 min read
Leader · Banking

The Amit Chandra Interview: Why Banking Needs a Ten-Year View

9 min read
Technology · Civil Aviation

Inside India's Civil Aviation Build-Out: Capex, Bottlenecks and the 2029 Target

10 min read
Sector · Waste Management

Green Hydrogen to Grid Storage: Inside the Waste Management Transition Investments

6 min read
Policy · Logistics

Compliance Window Opens for Logistics Units as Ministry of Commerce and Industry Tightens Standards

7 min read
Expert · Biotechnology

The Long Read: Biotechnology After the Tariff Reset

4 min read